Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
5/2/24 | Organogenesis (ORGO) | ReNu for Osteoarthritis | Subscribers Only | Subscribers Only | Subscribers Only |
5/2/24 | AstraZeneca (AZN) | Calquence for Mantle Cell Lymphoma - NHL | Subscribers Only | Subscribers Only | Subscribers Only |
4/29/24 | Annovis Bio (ANVS) | Buntanetap for Alzheimer's Disease (AD) | Subscribers Only | Subscribers Only | Subscribers Only |
4/29/24 | Daiichi Sankyo (4568) | Enhertu for HR+/HER2- Breast Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
4/29/24 | Merck (MRK) | V116 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
03/01/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
03/19/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
04/09/24 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
04/15/24 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |